Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05560100 · ClinicalTrials.gov registry record
Development of an Informed Consent Statement Which Communicates the Risk of Adverse Events Associated With Dry Needling
A clinical trial, sponsored by Youngstown State University.
- Completed
- Registry status
- 5
- Enrollment target
NCT05560100 is a clinical trial that has completed, run by Youngstown State University. The registered enrollment target is 5 participants.
The verdict
NCT05560100 has completed, sponsored by Youngstown State University.
- COMPLETED
- Registry status
- 5 participants
- Enrollment target
Study Summary
As Dry Needling (DN) continues to see increased use in the clinic, there is a need to establish adverse events that could occur as a result of DN intervention. The adverse events are important to consider when an individual needs to make an informed decision regarding their care. It is important to consider how such information should be presented during the informed consent process to improve an individual's ability to make a sound decision regarding their own personal care.
Interventions
- OTHER Nominal Group Technique - 2 to 3 hour virtual meeting
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2022-09-19 |
| Est. Completion | 2022-10-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05560100
The ClinicalTrials.gov registry entry for NCT05560100 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 5 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Youngstown State University, which has 19 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Nominal Group Technique - 2 to 3 hour virtual meeting is the first listed.
NCT05560100 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05560100 about?
NCT05560100 is a clinical study titled "Development of an Informed Consent Statement Which Communicates the Risk of Adverse Events Associated With Dry Needling". As Dry Needling (DN) continues to see increased use in the clinic, there is a need to establish adverse events that could occur as a result of DN intervention. The adverse events are important to consider when an individual needs to make an informed decision regarding their care. It is important to ...
What is the current status of trial NCT05560100?
This trial is currently completed. The enrollment target is 5 participants. The study started on 2022-09-19. Estimated completion is 2022-10-31.
What interventions are being tested in trial NCT05560100?
The interventions under investigation include: Nominal Group Technique - 2 to 3 hour virtual meeting (OTHER).
Who is sponsoring clinical trial NCT05560100?
This trial is sponsored by Youngstown State University, which has 19 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.